Preserving learned immunosuppressive placebo response: Perspectives for clinical application

Clinical Pharmacology and Therapeutics

Volumn 96, Issue 2, 2014, Pages 247-255

  Albring, A ^a   Wendt, L ^a   Benson, S ^a   Nissen, S ^a   Yavuz, Z ^a   Engler, H ^a   Witzke, O ^a   Schedlowski, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOPHARMACOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; MALE; PLACEBO EFFECT; PRIORITY JOURNAL; T LYMPHOCYTE; TASTE; VOLUNTEER;

ADOLESCENT; ADULT; CELLS, CULTURED; CYCLOSPORINE; DOUBLE-BLIND METHOD; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; PILOT PROJECTS; PLACEBO EFFECT; T-LYMPHOCYTES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904856075     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.75     Document Type: Article

References (40)

1. Enck, P., Benedetti, F. & Schedlowski, M. New insights into the placebo and nocebo responses. Neuron 59, 195-206 (2008 (Pubitemid 352033692)
2. Enck, P., Bingel, U., Schedlowski, M. & Rief, W. The placebo response in medicine: Minimize, maximize or personalize? Nat. Rev. Drug Discov. 12, 191-204 (2013
3. Finniss, D.G., Kaptchuk, T.J., Miller, F. & Benedetti, F. Biological, clinical, and ethical advances of placebo effects. Lancet 375, 686-695 (2010
4. Goebel, M.U. et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16, 1869-1873 (2002 (Pubitemid 35462605)
5. Goebel, M.U., Meykadeh, N., Kou, W., Schedlowski, M. & Hengge, U.R. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother. Psychosom. 77, 227-234 (2008 (Pubitemid 351685447)
6. Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S. & Rainero, I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 23, 4315-4323 (2003 (Pubitemid 36958452)
7. Albring, A. et al. Placebo effects on the immune response in humans: The role of learning and expectation. PLoS ONE 7, e49477 (2012
8. Wirth, T. et al. Repeated recall of learned immunosuppression: Evidence from rats and men. Brain Behav. Immun. 25, 1444-1451 (2011
9. Ober, K. et al. Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppression. Clin. Pharmacol. Ther. 91, 220-226 (2012
10. Giang, D.W. et al. Conditioning of cyclophosphamide-induced leukopenia in humans. J. Neuropsychiatry Clin. Neurosci. 8, 194-201 (1996 (Pubitemid 26138927)
11. Longo, D.L. et al. Conditioned immune response to interferon-gamma in humans. Clin. Immunol. 90, 173-181 (1999 (Pubitemid 29162162)
12. Stockhorst, U. et al. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response? Brain Behav. Immun. 14, 198-218 (2000 (Pubitemid 32280875)
13. Jones, R.E., Moes, N., Zwickey, H., Cunningham, C.L., Gregory, W.L. & Oken, B. Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning. Brain Behav. Immun. 22, 538-543 (2008
14. Ader, R. & Cohen, N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215, 1534-1536 (1982 (Pubitemid 12108711)
15. Klosterhalfen, S. & Klosterhalfen, W. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. Behav. Neurosci. 104, 716-724 (1990 (Pubitemid 20365635)
16. Bovbjerg, D.H. Conditioning, cancer, and immune regulation. Brain Behav. Immun. 17(suppl. 1), S58-S61 (2003
17. Gorczynski, R.M., Kennedy, M. & Ciampi, A. Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression. J. Immunol. 134, 4261-4266 (1985 (Pubitemid 15029659)
18. Schedlowski, M. & Pacheco-López, G. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24, 176-185 (2010
19. Doering, B.K. & Rief, W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol. Sci. 33, 165-172 (2012
20. Dudai, Y. The neurobiology of consolidations, or, how stable is the engram? Annu. Rev. Psychol. 55, 51-86 (2004 (Pubitemid 40517787)
21. Dudai, Y. The restless engram: Consolidations never end. Annu. Rev. Neurosci. 35, 227-247 (2012
22. Dudai, Y. & Eisenberg, M. Rites of passage of the engram: Reconsolidation and the lingering consolidation hypothesis. Neuron 44, 93-100 (2004 (Pubitemid 39348832)
23. Agren, T. et al. Disruption of reconsolidation erases a fear memory trace in the human amygdala. Science 337, 1550-1552 (2012
24. Eisenberg, M., Kobilo, T., Berman, D.E. & Dudai, Y. Stability of retrieved memory: Inverse correlation with trace dominance. Science 301, 1102-1104 (2003 (Pubitemid 37022313)
25. Hadamitzky, M., Engler, H. & Schedlowski, M. Learned immunosuppression: Extinction, renewal, and the challenge of reconsolidation. J. Neuroimmune Pharmacol. 8, 180-188 (2013
26. Ader, R. et al. Conditioned pharmacotherapeutic effects: A preliminary study. Psychosom. Med. 72, 192-197 (2010
27. Exton, M.S. et al. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. 276, R1710-R1717 (1999 (Pubitemid 29323536)
28. Sandler, A.D., Glesne, C.E. & Bodfish, J.W. Conditioned placebo dose reduction: A new treatment in attention-deficit hyperactivity disorder? J. Dev. Behav. Pediatr. 31, 369-375 (2010
29. Monfils, M.H., Cowansage, K.K., Klann, E. & LeDoux, J.E. Extinctionreconsolidation boundaries: Key to persistent attenuation of fear memories. Science 324, 951-955 (2009
30. Nader, K. & Hardt, O. A single standard for memory: The case for reconsolidation. Nat. Rev. Neurosci. 10, 224-234 (2009
31. Schiller, D., Monfils, M.H., Raio, C.M., Johnson, D.C., Ledoux, J.E. & Phelps, E.A. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463, 49-53 (2010
32. Tronson, N.C. & Taylor, J.R. Molecular mechanisms of memory reconsolidation. Nat. Rev. Neurosci. 8, 262-275 (2007 (Pubitemid 46452320)
33. Berman, D.E., Hazvi, S., Stehberg, J., Bahar, A. & Dudai, Y. Conflicting processes in the extinction of conditioned taste aversion: Behavioral and molecular aspects of latency, apparent stagnation, and spontaneous recovery. Learn. Mem. 10, 16-25 (2003 (Pubitemid 36177017)
34. Sai, P., Maugendre, D., Loreal, O., Maurel, C. & Pogu, S. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: Beta cell-Toxicity and rebound of insulitis after cessation of treatment. Diabete. Metab. 14, 455-462 (1988
35. Fite, K.V., Pardue, S., Bengston, L., Hayden, D. & Smyth, J.R. Jr. Effects of cyclosporine in spontaneous, posterior uveitis. Curr. Eye Res. 5, 787-796 (1986 (Pubitemid 17199409)
36. Hijnen, D.J., ten Berge, O., Timmer-de Mik, L., Bruijnzeel-Koomen, C.A.& De Bruin-Weller, M.S. Efficacy and safety of long-Term treatment with cyclosporin A for atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 21, 85-89 (2007 (Pubitemid 44942329)
37. Leineweber, K. et al. In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-Adrenoceptor polymorphism. Naunyn Schmiedebergs Arch. Pharmacol. 375, 303-309 (2007 (Pubitemid 46945336)
38. Zigmond, A.S. & Snaith, R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361-370 (1983 (Pubitemid 13098606)
39. Spielberger, C.D., Gorsuch, R.L., Lushene, R., Vagg, P.R & Jacobs, G.A. Manual for the State-Trait Anxiety Inventory (Palo Alto, CA: Consulting Psychologists Press, 1983
40. Rief, W., Barsky, A.J., Glombiewski, J.A., Nestoriuc, Y., Glaesmer, H. & Braehler, E. Assessing general side effects in clinical trials: Reference data from the general population. Pharmacoepidemiol. Drug Saf. 20, 405-415 (2011.